Adrenalectomy Guidelines for Elderly Female Patients

Initial Assessment and Indications for Surgery

The decision to remove an adrenal gland in an elderly female patient depends on whether the mass is functional, shows imaging features of malignancy, or demonstrates growth on surveillance, with quality of life and medical comorbidities being critical considerations in this population 1
All elderly patients with adrenal masses require comprehensive hormonal screening before any surgical decision, regardless of symptoms, including screening for autonomous cortisol secretion, pheochromocytoma, primary aldosteronism, and excess androgens 2, 3
Screening for autonomous cortisol secretion is done using 1 mg dexamethasone suppression test, with cortisol levels >138 nmol/L indicating autonomous secretion, 51-138 nmol/L suggesting possible secretion, and <50 nmol/L excluding it 2, 3
Screening for pheochromocytoma is done with plasma or 24-hour urinary metanephrines if the mass shows >10 HU on non-contrast CT or if the patient has signs of catecholamine excess 2
Screening for primary aldosteronism is done with aldosterone-to-renin ratio in patients with hypertension and/or hypokalemia, with a ratio >30 indicating hyperaldosteronism 2, 4

Pheochromocytoma must be resected in all cases to prevent fatal cardiovascular events, with alpha blockade for 1-3 weeks preoperatively being mandatory 1, 3
Aldosterone-secreting adenomas require laparoscopic adrenalectomy after confirmation with adrenal vein sampling, with medical management reserved for bilateral hyperplasia or nonsurgical candidates 1, 2, 3
Clinically apparent Cushing's syndrome mandates unilateral adrenalectomy of the affected gland to prevent severe metabolic derangements and increase surgical morbidity and mortality 2, 5, 6
Any mass with obvious malignancy features on CT requires surgical resection, with features including size >4 cm, heterogeneity, irregular margins, or evidence of invasion/necrosis 1, 2, 3

Younger elderly patients with mild autonomous cortisol secretion and progressive metabolic comorbidities can be considered for adrenalectomy after shared decision-making, with key considerations including presence of hypertension, type 2 diabetes, or asymptomatic vertebral fractures 1, 2, 5
Non-functional adrenal lesions that are radiologically benign but ≥4 cm should undergo repeat imaging in 6-12 months, with adrenalectomy considered if growth >5 mm/year or patient preference after discussing risks versus surveillance 2, 5

Quality of life and medical comorbidities must be carefully weighed when considering adrenalectomy in elderly patients, with age alone not being a contraindication to laparoscopic adrenalectomy 1, 2, 5
Laparoscopic approach is preferred when feasible as it reduces complications and promotes faster recovery, with conversion to open surgery occurring in approximately 3-11% of cases 2, 5

Benign non-functional adenomas <4 cm, myelolipomas, and other small masses containing macroscopic fat do not require further follow-up imaging or functional testing 2, 5
Indeterminate non-functional lesions require either repeat imaging in 3-6 months or surgical resection based on shared decision-making 2

Never proceed with any elective surgery in patients with undiagnosed or untreated functional adrenal pathology, as this can lead to life-threatening complications including cardiovascular collapse or metabolic crises 6
Always exclude pheochromocytoma before adrenal biopsy, as biopsy of unsuspected pheochromocytoma can trigger hypertensive crisis 2
Adrenal biopsy has limited clinical value and should not be part of initial workup except when metastatic disease from extra-adrenal malignancy would change management, and only after excluding pheochromocytoma 2, 3
Following bilateral adrenalectomy, lifelong glucocorticoid and mineralocorticoid replacement is mandatory with regular pituitary MRI monitoring to detect Nelson syndrome 6, 7, 8